Company Snapshot | January 21, 2020
The company was founded by Arnaud Muller‑Feuga (CSO), a former researcher at the French oceanographic institution IFREMER; Vincent Usache is the current CEO of the company. So far, the company has raised about $36.7 million, including a recent funding round of $32 million in July 2019. Among its ... To read more, click here.
Company Snapshot | May 04, 2020
The company was started by Doug Manofsky (CEO) and Craig Rouskey (CSO). To date, the company has raised approximately $435,000 in venture capital funding. Among its investors, we emphasize SOSV. The company develops genetically engineered probiotics for livestock; the company's technology is called ... To read more, click here.
Company Snapshot | June 23, 2020
The company was founded by Leonardo Álvarez (CEO) and Francia Navarrete (COO); the co‑founders have a background in computational enzyme design and bioinformatics; Protera was formerly known as GEA Enzymes and was originally based in Chile; as of June 2020, the company has relocated to France. So ... To read more, click here.
by Laura Krishfield
Through the deal, DSM is acquiring Erber Group's animal nutrition and health businesses Romer Labs and Biomin and will become the world leader in the mycotoxin risk management market. Romer Labs offers mycotoxin and food pathogen testing solutions, while Biomin provides feed additives that protect against mycotoxin contamination and increase gut performance. Biomin's product portfolio also includes livestock probiotics and phytogenics, which in recent years have garnered interest to promote livestock growth while reducing the use of antibiotics in feeds. As strict regulations covering veterinary medicinal products become fully enforced in the EU in 2022, clients should recognize this move has set DSM up for major growth.
For the original news article, click here .